Endometrial cancer care is becoming more personalized, and many patients are asked to make decisions based on information that is not always clearly explained. This conversation is meant to provide context, clarity, and a better understanding of how these decisions are made.
Katherine Fuh is a leading gynecologic oncologist at UCSF Health who is helping shape how endometrial cancer is treated today. Tune in to learn:
- What biomarker testing is and how it is used in endometrial cancer
- What results like MMR, MSI, p53, and POLE can mean for your treatment
- When immunotherapy is considered and why
- How treatment approaches can differ between early-stage and advanced disease
- What changes if the cancer returns
- How to think about clinical trials as part of your options
Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses or recommends any products or services. Consult your physician regarding any treatment or therapy.
